Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How can I effectively control the operating costs of a medicines business without compromising compliance?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q262 · Category F: Fees, Budget and Financial Planning (Q251-Q300)
In the pharmaceutical industry, cost control does not mean compromising on compliance; it means spending wisely. Effective strategies include: 1. “Optimise inventory management” by applying the first-in, first-out (FIFO) or first-expired, first-out (FEFO) principle and using software to forecast demand accurately, reducing losses from expired pharmaceutical products. 2. “Reduce energy consumption” by investing in energy-efficient air-conditioning and refrigeration equipment, which can save substantial electricity costs over the long term. 3. “Automate processes” by introducing automation tools for order processing, warehouse management and other operations to improve efficiency and reduce human error. 4. “Manage suppliers” by building good relationships with multiple suppliers and seeking better prices through bulk purchasing or long-term contracts, provided that all suppliers are legally licensed.

📘 Regulatory basis

Good Distribution Practice (GDP) and good pharmaceutical product storage practices inherently require efficiency and resource optimisation. A disorganised, wasteful system is itself non-compliant. For example, accurate stock records are one of the core GDP requirements.

📗 Drew Tang's recommendations

We recommend viewing compliance as an investment rather than a cost. For example, investment in staff training can reduce losses and fines resulting from operational errors. A robust Quality Management System (QMS) is the best tool for controlling operational risks and safeguarding long-term profitability.

📕 Risk notice

Any attempt to save costs at the expense of compliance is extremely short-sighted and dangerous. For example, using uncalibrated temperature and humidity monitors, hiring unqualified personnel or procuring medicines through illegal channels could, if discovered, result in severe consequences, including licence revocation, substantial fines or criminal prosecution.

Back to Category F: Fees, Budget and Financial Planning (Q251-Q300) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗